vantuylen

[From Eureka Alert, Sept 21, 2018] “Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART). The study appears September 21st in the journal Molecular Therapy.” For […]

[From NIH, Sept 18, 2018] “The National Institutes of Health has awarded $7.5 million for an international research program to prevent and treat HIV infection among adolescents and young adults in seven African countries and Brazil. The study, called Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H), will

[From New York Times, Sept 18, 2018] “In the United States, pharmaceutical companies have built a system which supports high costs for H.I.V. drugs. But that may be starting to change.” For more, click here.

[From Avert, Sept 14, 2018] “Is food insecurity a barrier to HIV testing or a risk factor for testing HIV-positive in South Africa? People who struggle to get food on the table are more likely to test positive for HIV in South Africa, according to a study of 2,742 adults testing for HIV at three primary

[From The Body Pro, Sept 17, 2018] “While many in the field of infectious disease research and medicine have noted the decline in new investigators and practitioners entering the workforce, the HIV Medical Association and the Infectious Disease Society of America have teamed up to do something about it. Over the summer, they announced a program